Marie L G Attwood

Project manager / Head pK/pd scientist - abx/ biofilm/phage researcher - surveillance lead & GNA NOW Lead scientist/quality manager

[Marie L G Attwood @Ree19872]

Collaborative research from PKPD lab (Bristol) and Becky Mayer Centre for phage @marthaClokie, is available on @ResearchGate: https://t.co/50PFHfPqF4

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

💥Drug resistance is rising, yet new antibiotics aren’t keeping pace – putting millions at risk.

GARDP is flipping the traditional R&D model by prioritizing high-burden countries, targeting drug-resistant infections and ensuring access from day one.

THIS IS BIG: https://t.co/pR4qWIhhCk

📢 Share this post and join the #ThisIsBig campaign.

#ThisIsBig #AMR

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

At GARDP, we’re changing the way #antibiotics are developed and accessed by

🛡️ Protecting adults from serious bacterial infections

👶 Helping newborns fight sepsis

💊 Treating drug-resistant gonorrhoea

🌍 Overcoming access barriers

🔬 Advancing new antibiotic discoveries

[Marie L G Attwood @Ree19872]

A privilege to present our work from the PKPD lab , NBT NHS Trust Bristol at ESCMID global

[Marie L G Attwood @Ree19872]

Please check out the lasted work driven by Yojana Gadiya et al research . Available on @ResearchGate: https://t.co/N97Dpp9MO6

[Laura Piddock 💙 @LauraPiddock]

📣📣 Grand Challenge announced 👇🏻: Innovations for Gram-Negative Antibiotic Discovery https://t.co/yIe7Fgf3OO

[Marie L G Attwood @Ree19872]

Find our latest manuscript collaboration. Its been a pleasure working on this project ://www.researchgate.net/publication/388566335_The_pharmacodynamics_of_fosfomycin_in_combination_with_meropenem_against_Klebsiella_pneumoniae_studied_in_an_in_vitro_model_of_infection

[Marie L G Attwood @Ree19872]

Our latest collaboration, #GNANOW https://t.co/iZ2vHHBio5

[Martha Clokie @MarthaClokie]

Why @Leicester_Phage - alongside our phage colleagues globally, are doing the work we do articulated in 30 seconds!

[ESCMID @ESCMID]

Two videos today for our series on the ESCMID/ASM Conference 2024: Alasdair MacGowan presents two works on treatments against Acinetobacter baumannii and NDM producing Escherichia coli.

📺📺 https://t.co/2nhwGtEvr3 📺📺

[Marie L G Attwood @Ree19872]

Check out our latest work from Bristol in collaboration with the University of Liverpool, Athens, Patras and Micron Ltd - Population pK/pD of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA https://t.co/XJNIf3o9eU

[Marie L G Attwood @Ree19872]

https://t.co/WFoLq86L6u

[Marie L G Attwood @Ree19872]

Please look at the latest research produced by the pK/pD lab, Bristol @ResearchGate: https://t.co/gSMEWlL5fN

[Marie L G Attwood @Ree19872]

Our research @MarthaClokie is available on @ResearchGate: https://t.co/azAsxeg48b

[Oded Rechavi @OdedRechavi]

Publishing a paper in a relatively decent journal

[Marie L G Attwood @Ree19872]

https://t.co/pZkTGoALTI

[Laura Piddock 💙 @LauraPiddock]

My latest article: Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance. Great collaboration with Tim Opperman and Alasdair MacGowan 🙂 https://t.co/miudJKCXRD

[Dr Heema Kumari Nilesh Vyas @HKNVee]

It’s out!
🥳🧫⚡️💧💜

We show that #ColdPlasma #PAW can be used as an effective pre-treatment strategy for #biofilm infected #ChronicWounds. We also suss out some of the mechanisms underpinning PAWs antimicrobial/anti-biofilm activity 💪🏽 🌟

[Martha Clokie @MarthaClokie]

Thanks everyone who came to the enjoyable + thought provoking 13th Oxford Phage Meeting. This was my concluding remarks - showing how the talks mapped to the which phages to use, how many and how will they interact with their environment. https://t.co/W7cEq323X5 #PhgOx23

[BSAC @BSACandJAC]

Adding either FOF or TOB to C/T at simulated human clinically observed concentrations reduced P. aeruginosa bacterial loads & the risk of C/T resistance when strains had C/T MICs at or above the clinical breakpoint:
https://t.co/Di85x8BTG3
@Ree19872 @OUPMedicine #JACNews